Cardior Pharmaceuticals was acquired by Novo Nordisk for 1.025 billion Euro
21 March 2024
21 March 2024
Total investments received (USD): N/A
Round value (USD): 1.11b
Round investors:
Novo A/S
Company: Cardior Pharmaceuticals
Related deals
CatalYm raised $150m in Series D funding co-led by Canaan Partners and Bioqube Ventures
Investments
04 July 2024
Isotopen Technologien München raised €188m in a round led by Temasek, joined by BlackRock, Qatar Investment Authority, Athos, and Carbyne.
Investments
01 June 2024
Tubulis raised €128m in a Series B extension backed by EQT Life Sciences and Nextech Invest
Investments
03 March 2024
Austria
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain
United Kingdom